Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians

被引:19
|
作者
Kapahi, Ruhi [1 ]
Guleria, Kamlesh [1 ]
Sambyal, Vasudha [1 ]
Manjari, Mridu [2 ]
Sudan, Meena [3 ]
Uppal, Manjit Singh [4 ]
Singh, Neeti Rajan [4 ]
机构
[1] Guru Nanak Dev Univ, Dept Human Genet, Human Cytogenet Lab, Amritsar 143005, Punjab, India
[2] Sri Guru Ram Das Inst Med Sci & Res, Dept Pathol, Amritsar, Punjab, India
[3] Sri Guru Ram Das Inst Med Sci & Res, Dept Radiotherapy, Amritsar, Punjab, India
[4] Sri Guru Ram Das Inst Med Sci & Res, Dept Surg, Amritsar, Punjab, India
关键词
Breast cancer; Polymorphism; VEGF; VEGFR1; ENDOTHELIAL-GROWTH-FACTOR; FACTOR GENE POLYMORPHISMS; SINGLE NUCLEOTIDE POLYMORPHISMS; INSERTION/DELETION POLYMORPHISM; HEPATOCELLULAR-CARCINOMA; DIABETIC-RETINOPATHY; MESSENGER-RNA; 936; C/T; EXPRESSION; SUSCEPTIBILITY;
D O I
10.1007/s13277-015-3059-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of present study was to evaluate the relationship between vascular endothelial growth factor (VEGF) -2578C/A, -2549I/D, -460T/C and -7C/T and VEGFR1 -710C/T polymorphisms with risk to breast cancer in North Indians. A total of 204 sporadic breast cancer patients and 204 controls were recruited for this case-control study. Significantly increased frequency of II genotype of -2549I/D polymorphism was observed in patients as compared to control individuals (odds ratio (OR) = 2.76, 95 % confidence interval (CI), 1.55-4.92; p = 0.0005). VEGF -2578AA genotype (OR = 2.87; 95 % CI, 1.61-5.10; p = 0.0003) and A allele (OR = 1.65, 95 % CI, 1.25-2.18; p = 0.0004) were found to be associated with increased risk for breast cancer. Individuals carrying CC genotype (OR = 2.23, 95 % CI, 1.25-3.97) and C allele (OR = 1.42, 95 % CI, 1.07-1.87) of VEGF -460T/C polymorphism were at higher risk of breast cancer. There was no significant difference in genotype and allele distribution of VEGF -7C/T and VEGFR1 -710C/T polymorphisms between cases and control individuals (p > 0.05). Linkage disequilibrium analysis showed a strong linkage between VEGF -2549I/D and -2578C/A polymorphisms (Lewontin's = 0.99; r (2) = 0.97), -2549I/D and -460T/C ( = 0.94; r (2) = 0.84), and -2578C/A and -460T/C polymorphisms ( = 0.93; r (2) = 0.83). In the present study, we concluded that VEGF -2549I/D, -2578C/A and -460T/C polymorphisms are associated with risk to breast cancer in Punjab, North India.
引用
收藏
页码:4223 / 4234
页数:12
相关论文
共 50 条
  • [41] Study of the Association between VEGF Polymorphisms and the Risk of Coronary Artery Disease in Koreans
    Ko, Eun-Ju
    Kim, In-Jai
    Lee, Jeong-Yong
    Park, Hyeon-Woo
    Park, Han-Sung
    Kim, Sang-Hoon
    Moon, Jae-Youn
    Sung, Jung-Hoon
    Kim, Nam-Keun
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [42] Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk
    Hung, Chih - chiang
    Wang, Yun - chi
    Shih, Hou - yu
    Liu, Chia - hua
    He, Jie - long
    Chen, Jaw - chyun
    Chang, Wen - shin
    Su, Chen - hsien
    Bau, Da - tian
    Tsai, Chia - wen
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (02) : 258 - 270
  • [43] Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis
    Sergentanis, Theodoros N.
    Economopoulos, Konstantinos P.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) : 229 - 234
  • [44] VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae
    Akriti S. Sahay
    Anjali T. Jadhav
    Deepali P. Sundrani
    Girija N. Wagh
    Savita S. Mehendale
    Preeti Chavan-Gautam
    Sadhana R. Joshi
    Molecular and Cellular Biochemistry, 2018, 438 : 141 - 152
  • [45] Epistatic interaction of Arg72Pro TP53 and −710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
    Patricia Rodrigues
    Jessica Furriol
    Eduardo Tormo
    Sandra Ballester
    Ana Lluch
    Pilar Eroles
    Molecular and Cellular Biochemistry, 2013, 379 : 181 - 190
  • [46] Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence
    Suspitsin, Evgeny N.
    Kashyap, Aniruddh
    Shelekhova, Kseniya V.
    Sokolenko, Anna P.
    Kuligina, Ekatherina Sh
    Iyevleva, Aglaya G.
    Kornilov, Alexandr V.
    Ehemann, Volker
    Yanus, Grigoriy A.
    Aleksakhina, Svetlana N.
    Preobrazhenskaya, Elena V.
    Zaitseva, Olga A.
    Yatsuk, Olga S.
    Klimashevsky, Valeriy F.
    Togo, Alexandr V.
    Imyanitov, Evgeny N.
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [47] Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
    H Bando
    H A Weich
    M Brokelmann
    S Horiguchi
    N Funata
    T Ogawa
    M Toi
    British Journal of Cancer, 2005, 92 : 553 - 561
  • [48] Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
    Bando, H
    Weich, HA
    Brokelmann, M
    Horiguchi, S
    Funata, N
    Ogawa, T
    Toi, M
    BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 553 - 561
  • [49] PTEN’s regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia
    Cheng Zhiyong
    Liang Wentong
    Yang Xiaoyang
    Pan Ling
    Medical Oncology, 2012, 29 : 1084 - 1092
  • [50] The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells
    Tang, Ping
    Li, Li
    Zhou, Yan
    Shen, Cong-Cong
    Kang, Yu-Huan
    Yao, Yu-Qin
    Yi, Cheng
    Gou, Lan-Tu
    Yang, Jin-Liang
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2014, 61 (04) : 376 - 384